NCT00104975 2016-12-15Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerYale UniversityPhase 1 Completed20 enrolled
NCT00080925 2012-03-08T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed20 enrolled